As associate director of Innovative Medicine at Yale Cancer Center, Dr. LoRusso is a nationally recognized expert in developing new cancer drugs through clinical trials.
She pioneered significant advances in medical oncology, drug development and early phase clinical trials in her work at Wayne State University’s Barbara Karmanos Cancer Institute as director of both the Phase I Clinical Trials Program and of the Eisenberg Center for Experimental Therapeutics.
Dr. LoRusso joined the Board of Scientific Counselors for the National Cancer Institute (NCI) and has served as the co-chair of their Cancer Therapy Evaluation Program Investigational Drug Steering Committee, the Board of Directors and numerous scientific committees of the American Association for Cancer Research, the education and scientific committees of the American Society of Clinical Oncology, and many peer-reviewed study sections and NCI committees.
Dr. LoRusso earned the Michigan State University Distinguished Alumni Award in 2014, an honorary doctor of science degree in 2015, and was honored as one of the National Organization of Italian American Women’s Three Wise Women in 2017.
